Brazilian scientists, particularly those from leading universities and research institutes, are pushing the boundaries of discovery in one of the world's harshest environments: Antarctica. In the ongoing 2025/2026 season of the Programa Antártico Brasileiro (PROANTAR), researchers are hunting for novel viruses and extremophile microbes that could unlock new treatments for diseases ranging from infections to cancer. This multidisciplinary effort, spearheaded by the Fiocruz's Fioantar project, highlights Brazil's growing role in polar science and underscores the contributions of its higher education institutions.

The Legacy of PROANTAR: Brazil's Antarctic Commitment

The Programa Antártico Brasileiro, launched in 1982, has evolved into a cornerstone of national scientific strategy. Coordinated by the Brazilian Navy's Interministerial Commission for Sea Resources (CIRM), PROANTAR supports annual expeditions known as OPERANTAR. The current 45th edition (2025/2026) builds on decades of presence at the Estação Antártica Comandante Ferraz (EACF), rebuilt in 2013 after a fire and now a hub for over 20 research projects annually.

Brazilian universities play a pivotal role. Institutions like the Universidade de São Paulo (USP), Universidade Federal do Rio Grande do Sul (UFRGS), Universidade Federal do Pampa (UNIPAMPA), and Universidade Federal Fluminense (UFF) contribute expertise in virology, microbiology, ecology, and human adaptation. These collaborations not only advance knowledge but also train the next generation of polar researchers through graduate programs and field opportunities.

Fioantar: Fiocruz's Flagship Virus Hunt and Bioprospecting Initiative

At the heart of the current expedition is Fioantar (Fiocruz na Antártica), a One Health approach integrating health surveillance, microbial biodiversity studies, and bioprospecting. Launched in 2019, the project entered a new phase in January 2026, with teams camping for up to 45 days near EACF to collect samples from soil, ice, seawater, animal feces, and directly from wildlife like penguins and petrels.

Fiocruz, closely tied to Brazilian universities through joint labs and training, leads efforts to detect emerging pathogens. Key targets include influenza viruses, rotaviruses, noroviruses, mycobacteria, and Bacillus species. The project's dual mission addresses threats—such as thawing permafrost releasing ancient microbes—and opportunities, like cold-adapted enzymes for biotech.

University Teams Driving Virus Surveillance

Brazilian universities are integral to Fioantar's virus surveillance. Researchers from UFRGS collaborated on genomic sequencing of H5N1 avian influenza strains found in Antarctic birds and seals in 2024, revealing multiple introduction routes from South America via migratory birds and marine mammals. This work, published as a preprint and under peer review, emphasizes the virus's adaptation for mammal-to-mammal transmission.

Earlier, IOC/Fiocruz teams with university partners detected Influenza A H11N2 in penguin feces in 2022, the first such finding in Antarctica. USP expeditions complement this by linking climate data to microbial shifts, as in the carbon-neutral Criosfera-1 mission studying ice melt's role in pathogen release.

UNIPAMPA's Fungal Discoveries

Universidade Federal do Pampa (UNIPAMPA) researchers have described four new macroscopic fungi species during recent PROANTAR expeditions. These extremophiles, adapted to subzero temperatures, offer bioprospecting potential for antifungals amid rising drug resistance. Led by Fernando Bertazzo, a former UNIPAMPA master's and PhD graduate, the findings highlight how university fieldwork yields novel taxa for pharmaceutical screening.

UFF's Human Health Focus

Universidade Federal Fluminense (UFF) contributes to Fioantar by studying mental health in isolated Antarctic camps. Their work monitors neurocognitive responses to extreme isolation, informing protocols for long-duration missions and astronaut training.

Bioprospecting Extremophiles: The Hunt for New Remedies

Antarctica's microbes thrive in conditions lethal to most life forms—subzero temperatures, high UV radiation, desiccation—making them ideal for bioprospecting. Brazilian university researchers target cold-active enzymes for detergents, diagnostics, and drugs; antibiotics to combat superbugs; and antitumor compounds.

For instance, UNIPAMPA's fungi produce unique secondary metabolites inhibiting pathogens. Broader PROANTAR projects from USP and UFRGS explore Bacillus subtilis strains for hydrocarbon bioremediation, with genomic insights revealing drug-like peptides. Past studies by Brazilian teams isolated Antarctic bacteria yielding leishmanicidal extracts, expanding to antiviral potentials.

Fiocruz's Fioantar update details how these microbes' biochemical strategies could yield "inexhaustible" sources for industry and medicine.

Daily Realities and Logistical Challenges

Life at EACF and field camps tests resilience. Temperatures hover -10°C to 10°C, but katabatic winds exceed 60 km/h, canceling outings. Constant daylight disrupts sleep; teams plan samples meticulously, processing in tent labs before Navy helicopter evacuations if needed. Adriana Vivoni, Fioantar coordinator, describes the "greening" of the Peninsula—less ice, more microbes—as a climate signal.

• Sampling Protocol: Sterile techniques prevent contamination; animal ethics under Antarctic Treaty.
• Lab Workflow: On-site PCR for viruses; samples shipped to Brazil for culturing and sequencing.
• Safety Measures: H5N1 biosafety protocols evolved post-2024 detections.

Impacts on Brazilian Higher Education and Careers

PROANTAR fosters interdisciplinary training. Over 137 researchers from 18 universities joined recent OPERANTARs, producing 100+ publications yearly. Programs like CNPq-funded calls build PhD pipelines, with alumni securing faculty positions at UFBA, USP, and beyond.

UFBA's neurocognitive studies exemplify human adaptation research, vital for space programs. These expeditions enhance Brazil's global standing, attracting international funding and collaborations with UC Berkeley and others.

Future Outlook: Pandemics, Biotech, and Sustainability

As ice melts, risks rise—ancient viruses or H5N1 spillover loom. Yet, bioprospecting promises breakthroughs: cold enzymes for green biotech, novel antibiotics amid AMR crisis. PROANTAR 2026/2027 eyes expanded camps and drone sampling.

For Brazilian universities, this cements leadership in polar science, driving jobs in virology, mycology, and biotech. Explore opportunities at AcademicJobs research positions.

Stakeholder Perspectives and Global Relevance

Navy logisticians praise university rigor; Fiocruz's Marilda Siqueira stresses genomic vigilance. Internationally, data shared via GISAID aids WHO pandemic prep. Brazil's neutral-carbon Criosfera-1 sets sustainability benchmarks.

This expedition exemplifies how Brazilian higher education turns frozen frontiers into medical frontiers, blending curiosity with urgency.

Photo by Thay Pellerin on Unsplash